Pancreatic cystic tumours: When to resect, when to observe

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 4, 2010, Pages 395-406

  Salvia, R ^a   Crippa, S ^a   Partelli, S ^a   Malleo, G ^a   Marcheggiani, G ^a   Bacchion, M ^a   Butturini, G ^a   Bassi, Claudio ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Pancreas neoplasms; Pancreatic cystic tumors

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; K RAS PROTEIN; MUCIN; MUCIN 1; MUCIN 2; PROTEIN P16; PROTEIN P53; TUMOR MARKER; VON HIPPEL LINDAU PROTEIN;

ABDOMINAL DISCOMFORT; ABDOMINAL MASS; ABDOMINAL PAIN; ANOREXIA; ASPIRATION BIOPSY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER MORPHOLOGY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOCARCINOMA; CYSTADENOMA; CYSTIC FIBROSIS; CYTOPLASM; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE DURATION; DYSPLASIA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FOLLOW UP; GASTROINTESTINAL OBSTRUCTION; HISTOLOGY; HUMAN; INCIDENCE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; JAUNDICE; LYMPH NODE DISSECTION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; MUCINOUS CARCINOMA; MULTIPLE CANCER; NECROSIS; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS DUCT; PANCREAS PSEUDOCYST; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATIC CYSTIC TUMOR; PANCREATICODUODENECTOMY; PAPILLOMA; PATHOLOGY; PREDICTOR VARIABLE; PROSPECTIVE STUDY; RADIODIAGNOSIS; RADIOGRAPHY; REOPERATION; REVIEW; SEX DIFFERENCE; SOLID TUMOR; STEATORRHEA; TUMOR BLEEDING; ULTRASOUND; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; CYSTADENOMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; PANCREATIC NEOPLASMS; PROGNOSIS;

EID: 77953147397     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. COMPAGNO J, OERTEL JE. Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases. Am J Clin Pathol 1978; 69: 289-298.
2. COMPAGNO J, OERTEL JE. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. Am J Clin Pathol 1978; 69: 573-580.
3. BECOURT PJ BG. Recherches sur le pancreas: ses fonctions et ses alterations organique. In: Strasbourg: FG Levrautl; 1830.
4. KLÖPPEL G SE, LONGNECKER DS, CAPELLA C, SOBIN LH. Histogical typing of tumours of the esocrine pancreas. World Health Organization International Histological Classification of Tumours. Berlin: Springer-Verlag, 1996.
5. WARSHAW AL. Mucinous cystic tumors and mucinous ductal ectasia of the pancreas. Gastrointest Endosc 1991; 37: 199-201.
6. BASSI C, SALVIA R, GUMBS AA, BUTTURINI G, FALCONI M, PEDERZOLI P. The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3. Langenbecks Arch Surg 2002; 387: 281-285.
7. BASSI C, SALVIA R, MOUNARI E, BIASUTTI C, FALCONI M, PEDERZOLI P. Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for symptoms and see at imaging or vice versa? World J Surg 2003; 27: 319-323.
8. NEUMANN HP, DINKEL E, BRAMBS H, WIMMER B, FRIEDBURG H, VOLK B, SIGMUND G, RIEGLER P, HAAG K, SCHOLLMEYER P, et al. Pancreatic lesions in the von Hippel-Lindau syndrome. Gastroenterology 1991; 101: 465-471.
9. GIRELLI R, BASSI C, FALCONI M, DE SANTO L, BONORA A, CALDIRON E, SARTORI N, SALVIA R, BRIANI G, PEDERZOLI P. Pancreatic cystic manifestations in von Hip- pel-Lindau disease. Int J Pancreatol 1997; 22: 101-109.
10. PROCACCI C, GRAZIANI R, BICEGO E, BERGAMO-ANDREIS IA, GUARISE A, VALDO M, BOGINA G, SOLARINO U, PISTOLESI GF. Serous cystadenoma of the pancreas: report of 30 cases with emphasis on the imaging findings. J Comput Assist Tomogr 1997; 21: 373-382.
11. PROCACCI C, BIASIUTTI C, CARBOGNIN G, ACCORDINI S, BICEGO E, GUARISE A, SPOTO E, ANDREIS IA, DE MARCO R, MEGIBOW AJ. Characterization of cystic tumors of the pancreas: CT accuracy. J Comput Assist Tomogr 1999; 23: 906-912.
12. NISHIHARA K, KAWABATA A, UENO T, MIYAHARA M, HAMANAKA Y, SUZUKI T. The differential diagnosis of pancreatic cysts by MR imaging. Hepatogastroenterology 1996; 43: 714-720.
13. CARBOGNIN G. Serous cystic tumors. New York: Springer-Verlag, 2003.
14. WIDMAIER U, MATTFELDT T, SIECH M, BEGER HG. Serous cystadenocarcinoma of the pancreas. Int J Pancreatol 1996; 20: 135-139.
15. ERIGUCHI N, AOYAGI S, NAKAYAMA T, HARA M, MIYAZAKI T, KUTAMI R, JIMI A. Serous cystadenocarcinoma of the pancreas with liver metastases. J Hepatobiliary Pancreat Surg 1998; 5: 467-470.
16. STROBEL O, Z'GRAGGEN K, SCHMITZ-WINNENTHAL FH, FRIESS H, KAPPELER A, ZIMMERMANN A, UHL W, BÜCHLER MW. Risk of malignancy in serous cystic neoplasms of the pancreas. Digestion 2003; 68: 24-33.
17. TSENG IF, WARSHAW AL, SAHANI DV, LAUWERS GY, RATTNER DW, FERNANDEZ-DEL CASTILLO C. Serous cystadenoma of the pancreas. Tumor growth rates and recommendations for treatment. Ann Surg 2005; 242: 413-421
18. ZAMBONI G, SCARPA A, BOGINA G, IACONO C, BASSI C, TALAMINI G, SESSA F, CAPELLA C, SOLCIA E, RICKAERT F, MARIUZZI GM, KLÖPPEL G. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999; 23: 410-422.
19. FURUKAWA T, TAKAHASHI T, KOBARI M, MATSUNO S. The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping. Cancer 1992; 70: 1505-1513.
20. SPERTI C, CAPPELLAZZO F, PASOUALI C, MILITELLO C, CATALINI S, BONADIMANI B, PEDRAZZOLI S. Cystic neoplasms of the pancreas: problems in differential diagnosis. Am Surg 1993; 59: 740-745
21. KOITO K, NAMIENO T, ICHIMURA T, YAMA N, HAREYAMA M, MORITA K, NISHI M. Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography. Radiology 1998; 208: 231-237
22. CRIPPA S, SALVIA R, WARSHAW AL, et al. Mucinous cystic neoplasm is not an aggressive entity. Lessons from 163 resected patients. Ann Surg 2008; 247: 571-579.
23. TANAKA M, CHARI S, ADSAY V, FERNANDEZ-DEL CASTILLO C, FALCONI M, SHIMIZU M, YAMAGUCHI K, YAMAO K, MATSUNO S. International Consensus Guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2005; 6: 17-32.
24. CARBOGNIN G, ZAMBONI G, PINALI L, CHIARA ED, GIRARDI V, SALVIA R, MUCELLI RP. Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up. Abdom Imaging 2006; 31: 320-325.
25. OHASHI K, MURAKAMI Y, MURAYAMA M, et al. Four cases of mucus secreting pancreatic cancer. Prog Dig Endoscopy 1982; 20: 348-351.
26. LIM JH, LEE G, OH YL. Radiologic spectrum of intraductal papillary mucinous tumor of the pancreas. Radiographics 2001; 21: 323-340
27. FALCONI M, SALVIA R, BASSI C, ZAMBONI G, TALAMINI G, PEDERZOLI P. Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 2001; 88: 376-381.
28. SOHN TA, YEO CJ, CAMERON JL, HRUBAN RH, FUKUSHIMA N, CAMPBELL KA, LILLEMOE KD. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004; 239: 788-797.
29. SALVIA R, FERNÁNDEZ-DEL CASTILLO C, BASSI C, THAYER SP, FALCONI M, MANTOVANI W, PEDERZOLI P, WARSHAW AL. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004; 239: 678-685.
30. CHARI ST, YADAV D, SMYRK TC, DIMAGNO EP, MILLER U, RAIMONDO M, GAIN JE, NORTON IA, PEARSON RK, PETERSEN BT, WIERSEMA MJ, FARNELL MB, SARR MG. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2002; 123: 1500-1507.
31. WADA K, TAKADA T, YASUDA H, AMANO H, YOSHIDA M, SUGIMOTO M, IRIE H. Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas? J Gastrointest Surg 2004; 8: 289-296.
32. CRIPPA S, FERNANDEZ-DEL CASTILLO C. Management of intraductal papillary mucinous neoplasms of the pancreas. Current Gastroenterology Reports 2008; 10: 136-1113
33. KOBARI M, EGAWA S, SHIBUYA K, SHIMAMURA H, SUNAMURA M, TAKEDA K, MATSUNO S, FURUKAWA T. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 1999; 134: 1131-1136.
34. TERRIS B, PONSOT P, PAYE F, HAMMEL P, SAUVANET A, MOLAS G, BERNADES P, BELGHITI J, RUSZNIEWSKI P, FLÉJOU JF. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000; 24: 1372-1377.
35. SUGIYAMA M, IZUMISATO Y, ABE N, MASAKI T, MORI T, ATOMI Y. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 2003; 90: 1244-1249.
36. SALVIA R, CRIPPA S, FALCONI M, BASSI C, GUARISE A, SCARPA A, PEDERZOLI P. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 2007; 56: 1086-1090.
37. RODRIGUEZ JR, SALVIA R, CRIPPA S, WARSHAW AL, BASSI C, FALCONI M, THAYER SP, LAUWERS GY, CAPELLI P, MINO-KENUDSON M, RAZO O, MCGRATH D, PEDERZOLI P, FERNÁNDEZ-DEL CASTILLO C. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 2007; 133: 72-79.
38. PILLEUL F, ROCHETTE A, PARTENSKY C, SCOAZEC JY, BERNARD P, VALETTE PJ. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings. J Magn Reson Imaging 2005; 21: 237-244.
39. SAUVANET A, PARTENSKY C, SASTRE B, GIGOT JF, FAGNIEZ PL, TUECH JJ, MILLAT B, BERDAH S, DOUSSET B, JAECK D, LE TREUT YP, LETOUBLON C. Medial pancreatectomy: a multi-institutional retrospective study of 53 patients by the French Pancreas Club. Surgery 2002; 132: 836-843.
40. CRIPPA S, BASSI C, WARSHAW AL, FALCONI M, PARTELLI S, THAYER SP, PEDERZOLI P, FERNÁNDEZ-DEL CASTILLO C. Middle pancreatectomy: indications, short- and long-term operative outcomes. Ann Surg 2007; 246: 69-76.
41. GIGOT JF, DEPREZ P, SEMPOUX C, DESGAMPS C, METAIRIE S, GUNEUR D, GIANELLO P. Surgical management of intraductal papillary mucinous tumors of the pancreas: the role of routine frozen section of the surgical margin, intraoperative endoscopic staged biopsies of the Wirsung duct, and pancreaticogastric anastomosis. Arch Surg 2001; 136: 1256-1262.
42. COUVELARD A, SAUVANET A, KIANMANESH R, HAMMEL P, COLNOT N, LÉVY P, RUSZNIEWSKI P, BEDOSSA P, BELGHITI J. Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable. A prospective evaluation. Ann Surg 2005; 242: 774-780.
43. EGUCHI H, ISHIKAWA O, OHIGASHI H, SASAKI Y, YAMADA T, NAKAIZUMI A, UEHARA H, TAKENAKA A, KASUGAI T, IMAOKA S. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Cancer 2006; 107: 2567-2575.
44. BASSI C, BUTTURINI G, SALVIA R, CRIPPA S, FALCONI M, PEDERZOLI P. Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study. J Gastrointest Surg 2006; 10: 1072-1080.
45. WADA K, KOZAREK RA, TRAVERSO LW. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg 2005; 189: 632-637
46. D'ANGELICA M, BRENNAN MF, SURIAWINATA AA, KLIMSTRA D, CONLON KC. Intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2004; 239: 400-408.
47. JANG JY, KIM SW, AHN YJ, YOON YS, CHOI MG, LEE KU, HAN JK, KIM WH, LEE YJ, KIM SC, HAN DJ, KIM YI, CHOI SH, CHO BH, YU HC, YOON DS, LEE WJ, LEE KB, KIM YC, LEE KS, KIM MW, KIM HJ, KIM HJ, PARK YH. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas:is it possible to predict the malignancy before surgery? Ann Surg Oncol 2005; 12: 124-132.
48. FRANTZ V. Tumours of the pancreas. Washington, DC: Armed Forces Institute of Pathology; 1959.
49. FERRARI L, SEREGNI E, BAJETTA E, MARTINETTI A, BOMBARDIERI E. The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours. Anticancer Res 1999; 19(4C): 3415-3427.
50. FALCONI MB, R. BASSI, C. SALVIA R. PEDERZOLI, P. Clinical manifestation and therapeutic management of non functioning endocrine tumours. In: Procacci CaM, A.J., editor. Imaging of the Pancreas. Cystic and Rare Tumors: Springer; 2003, pp. 153-160.
51. NG KH, TAN PH, THNG CH, OOI LL. Solid pseudopapillary tumour of the pancreas. ANZ J Surg 2003; 73: 410-415. (Pubitemid 36897822)